Search research articles
Contact Us
Filters
Showing results (121-130 of 144) with videos related to
Page
of 15
Sort By:
Nature Communications
|
September 15, 2021
Chromatin-based, in cis and in trans regulatory rewiring underpins distinct oncogenic transcriptomes in multiple myeloma
Jaime Alvarez-Benayas, Nikolaos Trasanidis, Alexia Katsarou, et al.
Blood
|
November 22, 2012
Clinical drug resistance linked to interconvertible phenotypic and functional states of tumor-propagating cells in multiple myeloma
Aristeidis Chaidos, Chris P Barnes, Gillian Cowan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 25, 2015
The Stat3/5 Signaling Biosignature in Hematopoietic Stem/Progenitor Cells Predicts Response and Outcome in Myelodysplastic Syndrome Patients Treated with Azacitidine
Paraskevi Miltiades, Eleftheria Lamprianidou, Theodoros P Vassilakopoulos, et al.
European Journal of Haematology
|
July 5, 2017
Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma patients in the era of novel antimyeloma therapies
Flora Zagouri, Efstathios Kastritis, Athanasios Zomas, et al.
Leukemia & Lymphoma
|
November 15, 2018
Chronic myelomonocytic leukemia treated with 5-azacytidine - results from the Hellenic 5-Azacytidine Registry: proposal of a new risk stratification system
Panagiotis T Diamantopoulos, Ioannis Kotsianidis, Argiris Symeonidis, et al.
Scientific Reports
|
November 18, 2024
biobank.cy: the Biobank of Cyprus past, present and future
Eleni M Loizidou, Maria Kyratzi, Maria A Tsiarli, et al.
Biorxiv : the Preprint Server for Biology
|
August 14, 2023
Systematic characterization of therapeutic vulnerabilities in Multiple Myeloma with Amp1q reveals increased sensitivity to the combination of MCL1 and PI3K inhibitors
Romanos Sklavenitis-Pistofidis, Elizabeth D Lightbody, Mairead Reidy, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 30, 2019
Characteristics of Long-Term Survival in Patients With Myelodysplastic Syndrome Treated With 5-Azacyditine: Results From the Hellenic 5-Azacytidine Registry
Panagiotis T Diamantopoulos, Vasiliki Pappa, Argiris Symeonidis, et al.
Hematological Oncology
|
June 5, 2020
Estimated glomerular filtration rate independently predicts outcome of azacitidine therapy in higher-risk Myelodysplastic syndromes. Results from 536 patients of the Hellenic National Registry of Myelodysplastic and Hypoplastic syndromes
Vasileios Papadopoulos, Panagiotis T Diamantopoulos, Sotirios G Papageorgiou, et al.
British Journal of Haematology
|
May 6, 2025
Real-life experience of luspatercept in transfusion-dependent lower risk myelodysplastic syndrome patients
Anthi Bouchla, Sotirios G Papageorgiou, Ioannis Kotsianidis, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 144) with videos related to
Sort By:
Page
of 15
Nature Communications
|
September 15, 2021
Chromatin-based, in cis and in trans regulatory rewiring underpins distinct oncogenic transcriptomes in multiple myeloma
Jaime Alvarez-Benayas, Nikolaos Trasanidis, Alexia Katsarou, et al.
Blood
|
November 22, 2012
Clinical drug resistance linked to interconvertible phenotypic and functional states of tumor-propagating cells in multiple myeloma
Aristeidis Chaidos, Chris P Barnes, Gillian Cowan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 25, 2015
The Stat3/5 Signaling Biosignature in Hematopoietic Stem/Progenitor Cells Predicts Response and Outcome in Myelodysplastic Syndrome Patients Treated with Azacitidine
Paraskevi Miltiades, Eleftheria Lamprianidou, Theodoros P Vassilakopoulos, et al.
European Journal of Haematology
|
July 5, 2017
Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma patients in the era of novel antimyeloma therapies
Flora Zagouri, Efstathios Kastritis, Athanasios Zomas, et al.
Leukemia & Lymphoma
|
November 15, 2018
Chronic myelomonocytic leukemia treated with 5-azacytidine - results from the Hellenic 5-Azacytidine Registry: proposal of a new risk stratification system
Panagiotis T Diamantopoulos, Ioannis Kotsianidis, Argiris Symeonidis, et al.
Scientific Reports
|
November 18, 2024
biobank.cy: the Biobank of Cyprus past, present and future
Eleni M Loizidou, Maria Kyratzi, Maria A Tsiarli, et al.
Biorxiv : the Preprint Server for Biology
|
August 14, 2023
Systematic characterization of therapeutic vulnerabilities in Multiple Myeloma with Amp1q reveals increased sensitivity to the combination of MCL1 and PI3K inhibitors
Romanos Sklavenitis-Pistofidis, Elizabeth D Lightbody, Mairead Reidy, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 30, 2019
Characteristics of Long-Term Survival in Patients With Myelodysplastic Syndrome Treated With 5-Azacyditine: Results From the Hellenic 5-Azacytidine Registry
Panagiotis T Diamantopoulos, Vasiliki Pappa, Argiris Symeonidis, et al.
Hematological Oncology
|
June 5, 2020
Estimated glomerular filtration rate independently predicts outcome of azacitidine therapy in higher-risk Myelodysplastic syndromes. Results from 536 patients of the Hellenic National Registry of Myelodysplastic and Hypoplastic syndromes
Vasileios Papadopoulos, Panagiotis T Diamantopoulos, Sotirios G Papageorgiou, et al.
British Journal of Haematology
|
May 6, 2025
Real-life experience of luspatercept in transfusion-dependent lower risk myelodysplastic syndrome patients
Anthi Bouchla, Sotirios G Papageorgiou, Ioannis Kotsianidis, et al.
Page
of 15